• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化照射条件增强全灭活流感病毒疫苗的免疫原性。

Enhanced Immunogenicity of a Whole-Inactivated Influenza A Virus Vaccine Using Optimised Irradiation Conditions.

机构信息

Research Centre for Infectious Diseases, Department of Molecular and Biomedical Sciences, University of Adelaide, Adelaide, SA, Australia.

Gamma Vaccines Pty Ltd, Yarralumla, ACT, Australia.

出版信息

Front Immunol. 2021 Nov 24;12:761632. doi: 10.3389/fimmu.2021.761632. eCollection 2021.

DOI:10.3389/fimmu.2021.761632
PMID:34899711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8652198/
Abstract

Influenza A virus presents a constant pandemic threat due to the mutagenic nature of the virus and the inadequacy of current vaccines to protect against emerging strains. We have developed a whole-inactivated influenza vaccine using γ-irradiation (γ-Flu) that can protect against both vaccine-included strains as well as emerging pandemic strains. γ-irradiation is a widely used inactivation method and several γ-irradiated vaccines are currently in clinical or pre-clinical testing. To enhance vaccine efficacy, irradiation conditions should be carefully considered, particularly irradiation temperature. Specifically, while more damage to virus structure is expected when using higher irradiation temperatures, reduced radiation doses will be required to achieve sterility. In this study, we compared immunogenicity of γ-Flu irradiated at room temperature, chilled on ice or frozen on dry ice using different doses of γ-irradiation to meet internationally accepted sterility assurance levels. We found that, when irradiating at sterilising doses, the structural integrity and vaccine efficacy were well maintained in all preparations regardless of irradiation temperature. In fact, using a higher temperature and lower radiation dose appeared to induce higher neutralising antibody responses and more effective cytotoxic T cell responses. This outcome is expected to simplify irradiation protocols for manufacturing of highly effective irradiated vaccines.

摘要

甲型流感病毒由于其病毒的突变性质和当前疫苗无法有效预防新兴毒株,因此一直构成着不断的大流行威胁。我们已经开发了一种使用γ-射线(γ-Flu)的全灭活流感疫苗,该疫苗可以预防包括疫苗株在内的新兴大流行株。γ-射线辐照是一种广泛使用的灭活方法,目前有几种γ-射线辐照疫苗正在临床或临床前研究中。为了提高疫苗的效力,应仔细考虑辐照条件,特别是辐照温度。具体而言,虽然使用较高的辐照温度预计会对病毒结构造成更大的损害,但为了达到无菌状态,所需的辐射剂量将会减少。在这项研究中,我们比较了使用不同剂量的γ-射线在室温、冰上冷却或干冰上冷冻辐照的γ-Flu 的免疫原性,以达到国际公认的无菌保证水平。我们发现,在进行杀菌剂量的辐照时,所有制剂的结构完整性和疫苗效力都得到了很好的维持,无论辐照温度如何。事实上,使用较高的温度和较低的辐射剂量似乎会引起更高的中和抗体反应和更有效的细胞毒性 T 细胞反应。这一结果有望简化用于制造高效灭活疫苗的辐照方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/df27b8985050/fimmu-12-761632-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/8b645c9bcf84/fimmu-12-761632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/9c412161a9f3/fimmu-12-761632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/b3be75c2a697/fimmu-12-761632-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/44d1a05a5c50/fimmu-12-761632-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/2aca4d4ecfdc/fimmu-12-761632-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/fb1cef1be53a/fimmu-12-761632-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/df27b8985050/fimmu-12-761632-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/8b645c9bcf84/fimmu-12-761632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/9c412161a9f3/fimmu-12-761632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/b3be75c2a697/fimmu-12-761632-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/44d1a05a5c50/fimmu-12-761632-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/2aca4d4ecfdc/fimmu-12-761632-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/fb1cef1be53a/fimmu-12-761632-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc6c/8652198/df27b8985050/fimmu-12-761632-g007.jpg

相似文献

1
Enhanced Immunogenicity of a Whole-Inactivated Influenza A Virus Vaccine Using Optimised Irradiation Conditions.优化照射条件增强全灭活流感病毒疫苗的免疫原性。
Front Immunol. 2021 Nov 24;12:761632. doi: 10.3389/fimmu.2021.761632. eCollection 2021.
2
The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.γ射线辐照条件对全灭活甲型流感病毒疫苗免疫原性的影响。
Vaccine. 2017 Feb 15;35(7):1071-1079. doi: 10.1016/j.vaccine.2016.12.044. Epub 2017 Jan 18.
3
Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.NKT细胞激动剂α-半乳糖神经酰胺的辅助使用可增强基于M2的DNA疫苗的免疫原性及对甲型流感病毒的保护性免疫。
Arch Virol. 2017 May;162(5):1251-1260. doi: 10.1007/s00705-017-3230-7. Epub 2017 Jan 24.
4
A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.一种将H7血凝素跨膜结构域替换为H3结构域的重组H7N9流感疫苗可诱导小鼠产生更多的交叉反应抗体,并增强不同进化枝间的保护作用。
Antiviral Res. 2017 Jul;143:97-105. doi: 10.1016/j.antiviral.2017.03.029. Epub 2017 Apr 10.
5
Protective efficacy of a bivalent inactivated reassortant H1N1 influenza virus vaccine against European avian-like and classical swine influenza H1N1 viruses in mice.两价灭活重配 H1N1 流感病毒疫苗对欧洲禽流感样和经典猪源 H1N1 流感病毒在小鼠体内的保护效力。
Vet Microbiol. 2020 Jul;246:108724. doi: 10.1016/j.vetmic.2020.108724. Epub 2020 May 19.
6
T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.用减毒活流感疫苗进行初免-加强免疫引发的T细胞介导的跨毒株保护性免疫。
Int J Infect Dis. 2014 Oct;27:37-43. doi: 10.1016/j.ijid.2014.05.016. Epub 2014 Aug 27.
7
Return of inactivated whole-virus vaccine for superior efficacy.灭活全病毒疫苗的回归带来更高的疗效。
Immunol Cell Biol. 2012 Jul;90(6):571-8. doi: 10.1038/icb.2011.70. Epub 2011 Aug 16.
8
Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.对展示来自H1、H3和B亚型流感HA2的三价嵌合诺如病毒P颗粒免疫原的免疫原性和保护作用的评估。
Emerg Microbes Infect. 2016 May 25;5(5):e51. doi: 10.1038/emi.2016.51.
9
Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model.经白细胞介素 28B 佐剂增强的全γ 射线照射流感 A(H1N1 亚型)疫苗经鼻腔给药后在小鼠模型中的保护性细胞和黏膜免疫应答。
Arch Virol. 2021 Feb;166(2):545-557. doi: 10.1007/s00705-020-04900-3. Epub 2021 Jan 6.
10
Broadly Protective CD8 T Cell Immunity to Highly Conserved Epitopes Elicited by Heat Shock Protein gp96-Adjuvanted Influenza Monovalent Split Vaccine.热休克蛋白 gp96 佐剂流感单价裂解疫苗诱导广泛保护性 CD8 T 细胞免疫应答针对高度保守表位。
J Virol. 2021 May 24;95(12). doi: 10.1128/JVI.00507-21.

引用本文的文献

1
Application of C Heavy Ion-Irradiated BHK-21 Cells in Production of Foot-and-Mouth Disease Vaccine.碳重离子辐照BHK-21细胞在口蹄疫疫苗生产中的应用
Vet Sci. 2025 Feb 13;12(2):167. doi: 10.3390/vetsci12020167.
2
Influenza Virus Inactivated by Heavy Ion Beam Irradiation Stimulates Antigen-Specific Immune Responses.重离子束辐照灭活的流感病毒刺激抗原特异性免疫反应。
Pharmaceutics. 2024 Mar 27;16(4):465. doi: 10.3390/pharmaceutics16040465.
3
Distinct immune responses in the early phase to natural SARS-CoV-2 infection or vaccination.

本文引用的文献

1
Sterility of gamma-irradiated pathogens: a new mathematical formula to calculate sterilizing doses.辐照病原体的无菌性:一种计算灭菌剂量的新数学公式。
J Radiat Res. 2020 Nov 16;61(6):886-894. doi: 10.1093/jrr/rraa076.
2
Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses.流感 H3 和 H1 病毒对 HA 茎抗体的耐药性存在不同的遗传屏障。
Science. 2020 Jun 19;368(6497):1335-1340. doi: 10.1126/science.aaz5143.
3
Effect of Gamma Irradiation on the Antibody Response Measured in Human Serum from Subjects Vaccinated with Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine.
自然感染 SARS-CoV-2 或接种疫苗后早期的独特免疫反应。
J Med Virol. 2022 Dec;94(12):5691-5701. doi: 10.1002/jmv.28034. Epub 2022 Aug 6.
4
Protective Efficacy of H9N2 Avian Influenza Vaccines Inactivated by Ionizing Radiation Methods Administered by the Parenteral or Mucosal Routes.电离辐射法灭活的H9N2禽流感疫苗经肠外或黏膜途径接种后的保护效力
Front Vet Sci. 2022 Jul 11;9:916108. doi: 10.3389/fvets.2022.916108. eCollection 2022.
5
Low-Energy Electron Irradiation of Tick-Borne Encephalitis Virus Provides a Protective Inactivated Vaccine.低能电子辐照蜱传脑炎病毒可提供保护性灭活疫苗。
Front Immunol. 2022 Mar 7;13:825702. doi: 10.3389/fimmu.2022.825702. eCollection 2022.
γ 射线辐射对用重组单纯疱疹病毒-扎伊尔埃博拉病毒包膜糖蛋白疫苗免疫的受试者血清中抗体应答的影响。
Am J Trop Med Hyg. 2019 Jul;101(1):207-213. doi: 10.4269/ajtmh.19-0076.
4
Direct interaction of whole-inactivated influenza A and pneumococcal vaccines enhances influenza-specific immunity.全灭活流感疫苗和肺炎球菌疫苗的直接相互作用增强了流感特异性免疫。
Nat Microbiol. 2019 Aug;4(8):1316-1327. doi: 10.1038/s41564-019-0443-4. Epub 2019 May 20.
5
Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole-cell inactivated pneumococcal vaccine.肺炎球菌表面抗原 A 突变株全细胞灭活肺炎球菌疫苗的安全性和免疫原性增强。
Immunol Cell Biol. 2019 Sep;97(8):726-739. doi: 10.1111/imcb.12257. Epub 2019 May 23.
6
Gamma-irradiated rotavirus: A possible whole virus inactivated vaccine.γ-射线辐照轮状病毒:一种可能的全病毒灭活疫苗。
PLoS One. 2018 Jun 7;13(6):e0198182. doi: 10.1371/journal.pone.0198182. eCollection 2018.
7
A Standard Method To Inactivate Bacillus anthracis Spores to Sterility via Gamma Irradiation.一种通过伽马辐照使炭疽芽孢杆菌孢子达到无菌的标准方法。
Appl Environ Microbiol. 2018 May 31;84(12). doi: 10.1128/AEM.00106-18. Print 2018 Jun 15.
8
The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated Influenza A virus vaccine.γ射线辐照条件对全灭活甲型流感病毒疫苗免疫原性的影响。
Vaccine. 2017 Feb 15;35(7):1071-1079. doi: 10.1016/j.vaccine.2016.12.044. Epub 2017 Jan 18.
9
First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.灭活全HIV-1疫苗的首次I期人体临床试验:安全性验证及抗HIV抗体反应增强
Retrovirology. 2016 Nov 28;13(1):82. doi: 10.1186/s12977-016-0317-2.
10
Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.接种PfSPZ疫苗后1年的疟疾防护及免疫相关因素
Nat Med. 2016 Jun;22(6):614-23. doi: 10.1038/nm.4110. Epub 2016 May 9.